Services giants Technip and FMC Technologies have received speedy clearance from US antitrust authorities for their proposed $13 billion merger.
The French engineering giant and Houston-based FMC were given the all-clear under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, they said on Monday.
The companies must, however, overcome antitrust reviews in other countries, we well as shareholder approval, other regulatory consents and additional customary closing conditions. The deal is set to close early next year.
FMC and Technip signed a memorandum of understanding in mid-May to merge in an all-stock transaction, with each company’s shareholders to own close to 50% of the combined entity that will be named TechnipFMC.
The fusion, which would build on their existing joint venture Forsys Subsea, will enable the companies to achieve pre-tax cost synergies of about $200 million in 2018 and at least $400 million annually from 2019 onwards, they said last month.
Implementation costs of the merger are estimated at $250 million.
Full Content: Oil and gas investor
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas